PMCF and PMPF Documentation for Medical Devices and IVDs: An Overview
Post-market clinical and performance follow-up is shifting from a documentation-only requirement to a proactive, data-driven lifecycle function. Under the EU MDR and EU IVDR, manufacturers are expected to systematically collect, analyse, and interpret post-market evidence to identify trends, evaluate emerging risks, and keep clinical or performance evaluation conclusions current as real-world product experience evolves.
This creates an opportunity for manufacturers to use PMCF and PMPF as more than compliance outputs. Well-structured PMCF Plans, PMPF Plans, PMCF Evaluation Reports, and PMPF Evaluation Reports can improve traceability across CER/PER, PMS, PMSR/PSUR, risk management, labeling, IFU, SSCP/SSP, and technical documentation while supporting stronger benefit-risk evaluation and audit readiness across the product lifecycle.
Freyr supports manufacturers in building structured PMCF and PMPF documentation frameworks aligned with EU MDR and EU IVDR expectations. By combining regulatory insight, clinical and performance evaluation expertise, PMS knowledge, evidence-generation support, and systematic documentation methodologies, Freyr helps manufacturers translate post-market data into clear, traceable, and lifecycle-ready regulatory conclusions.
PMSP vs PMSR vs PSUR (EU MDR & IVDR Framework)
Under EU MDR and IVDR, Post-Market Surveillance (PMS) documentation is structured around key deliverables that define how post-market data is collected, evaluated, and reported throughout the device lifecycle. Articles 83–86 of the EU MDR and the corresponding IVDR provisions establish requirements for Post-Market Surveillance Plans, Post-Market Surveillance Reports, and Periodic Safety Update Reports (PSUR), while Annex III provides detailed guidance on the structure and content of the documentation.
| Document / Activity | Purpose | Applies To | MDR / IVDR Context |
|---|---|---|---|
| PMCF Plan | Defines post-market clinical data collection and evaluation methodology | Medical devices | EU MDR; supports clinical evaluation and PMS |
| PMPF Plan | Defines post-market performance and scientific data collection and evaluation methodology | IVDs | EU IVDR; supports performance evaluation and PMS |
| PMCF Evaluation Report | Summarizes and interprets PMCF results | Medical devices | Feeds CER, PMS, PMSR/PSUR, RMF, SSCP, labeling, IFU, and technical documentation |
| PMPF Evaluation Report | Summarizes and interprets PMPF results | IVDs | Feeds PER, PMS, PMSR/PSUR, RMF, SSP, labeling, IFU, and technical documentation |
| PMS Plan | Defines broader post-market surveillance methodology | Medical devices and IVDs | Required under MDR and IVDR; includes PMCF or PMPF where applicable |
| PMSR | Summarizes PMS results for lower-risk products | MDR Class I devices; IVDR Class A and B IVDs | Classification-based reporting output |
| PSUR | Periodic safety and performance evaluation | Higher-risk medical devices and IVDs | MDR Class IIa+ devices; IVDR Class C and D IVDs |
Freyr’s PMCF and PMPF Documentation Services
Freyr supports manufacturers with end-to-end PMCF and PMPF documentation services, including the development, evaluation, remediation, and maintenance of PMCF Plans, PMPF Plans, PMCF Evaluation Reports, and PMPF Evaluation Reports. Our approach combines regulatory expertise with structured documentation methodologies to support EU MDR and EU IVDR alignment, enable effective post-market evidence analysis, strengthen benefit-risk evaluation, and ensure audit-ready documentation across the product lifecycle.
PMCF/PMPF Plan Development
The PMCF/PMPF Plan defines how post-market clinical or performance data will be systematically collected, analyzed, and evaluated to support continued assessment of device safety, performance, intended purpose, claims, and benefit-risk conclusions. For medical devices, the PMCF Plan supports the EU MDR clinical evaluation and PMS lifecycle. For IVDs, the PMPF Plan supports ongoing performance evaluation under EU IVDR, linked to intended purpose, risk profile, existing evidence, and evidence gaps.
Freyr supports manufacturers in developing structured PMCF and PMPF Plans aligned with EU MDR and EU IVDR expectations, covering evidence gap assessment, objectives, data sources, methodology rationale, timelines, responsibilities, evaluation criteria, and traceability to CER/PER, PMS, PMSR/PSUR, risk management, SSCP/SSP, labeling, IFU, and technical documentation.
PMCF/PMPF Evaluation Report Preparation
The PMCF/PMPF Evaluation Report summarizes completed follow-up activities and explains how post-market clinical or performance evidence supports continued device safety, performance, benefit-risk conclusions, and lifecycle evaluation. For medical devices, the PMCF Evaluation Report supports CER updates under EU MDR. For IVDs, the PMPF Evaluation Report supports PER updates under EU IVDR by evaluating whether post-market performance evidence continues to support scientific validity, analytical performance, clinical performance, intended purpose, and performance claims.
Freyr supports PMCF and PMPF Evaluation Report preparation by converting post-market clinical and performance evidence into structured, audit-ready documentation aligned with PMCF/PMPF objectives, CER/PER updates, PMS requirements, risk management conclusions, PMSR/PSUR, RMF, SSCP/SSP, labeling, IFU, and technical documentation.
PMCF/PMPF Documentation Gap Assessment
PMCF and PMPF documentation gap assessment helps manufacturers evaluate whether existing follow-up documentation is complete, specific, justified, and aligned with EU MDR or EU IVDR expectations. This includes reviewing evidence gaps, selected methods, data sources, reporting outputs, cross-document traceability, and links to CER/PER, PMS, PMSR/PSUR, RMF, SSCP/SSP, labeling, IFU, and technical documentation.
Freyr conducts structured PMCF/PMPF gap assessments supported by remediation roadmaps to strengthen documentation quality, improve regulatory alignment, and prepare for audits, Notified Body comments, observations, or remediation activities.
PMCF/PMPF Documentation Maintenance and Lifecycle Updates
PMCF and PMPF documentation must be maintained as new post-market evidence becomes available through complaints, vigilance data, literature, surveys, registries, real-world evidence, clinical or performance findings, and trend analyses. Regular updates help ensure documentation reflects the current safety and performance profile of the product and supports benefit-risk evaluation.
Freyr supports lifecycle maintenance by integrating new evidence into PMCF/PMPF Plans, PMCF/PMPF Evaluation Reports, CER/PER updates, PMS outputs, PMSR/PSUR conclusions, risk management documentation, labeling, IFU, and technical documentation.
PMCF/PMPF Survey, RWE, Registry, and Literature Support
PMCF and PMPF evidence-generation activities should be selected based on the evidence question, product risk profile, intended purpose, claims, available data, and regulatory expectations. Methods may include PMCF surveys, PMCF clinical investigations, PMPF performance studies, registry analysis, retrospective data review, real-world evidence, literature review, systematic literature review, and stakeholder feedback from clinicians, laboratory professionals, users, or patients.
Freyr supports PMCF survey services, PMCF Survey Report preparation, PMCF study strategy, PMPF performance study planning, RWE generation, registry-based evidence, and literature support that may feed into PMCF/PMPF Evaluation Reports, CER/PER updates, PMSR/PSUR conclusions, and RMF updates.
Notified Body Comment and Remediation Support
PMCF and PMPF-related Notified Body comments or observations often arise when plans are too generic, evidence gaps are unclear, method selection is weak, survey or study outputs are not interpreted, or conclusions are inconsistent across CER/PER, PMS, PMSR/PSUR, risk management, and technical documentation.
Freyr supports manufacturers in reviewing Notified Body feedback, identifying documentation gaps, strengthening PMCF/PMPF rationale, updating plans and evaluation reports, and preparing structured response packages that maintain traceability across lifecycle documentation and support remediation timelines.
Book a meeting with our experts today
- Schedule a call today
Post-Market Clinical and Performance Follow-Up Documentation
- EU MDR PMCF and EU IVDR PMPF documentation expertise across medical devices and IVDs
- Support for PMCF Plans, PMPF Plans, PMCF Evaluation Reports, and PMPF Evaluation Reports
- Clinical evaluation, performance evaluation, PMS, risk management, and evidence-generation capabilities
- Experience with PMCF surveys, PMPF surveys, real-world evidence, registries, literature reviews, SLRs, retrospective data analysis, PMCF clinical investigations, and PMPF performance studies
- Support for Notified Body comments, observations, remediation activities, and lifecycle documentation updates
- Structured, SOP-driven approach that supports consistency and documentation quality
- Strong traceability across CER/PER, PMS, PMSR/PSUR, RMF, SSCP/SSP, labeling, IFU, and technical documentation
- Scalable support for single-device, multi-device, and portfolio-level documentation needs
- Ability to support timelines driven by certification milestones, surveillance cycles, and Notified Body remediation commitments
- Integrated delivery model across clinical evaluation, performance evaluation, PMS, risk, and regulatory functions
Why Partner with Freyr?
- Strengthen MDR and IVDR lifecycle compliance with regulator-ready PMCF and PMPF evidence
- Improve alignment between post-market evidence, benefit-risk conclusions, and technical documentation
- Reduce gaps between PMCF/PMPF outputs and CER, PER, PMSR, PSUR, RMF, SSCP, SSP, labeling, and IFU updates
- Support certification, recertification, surveillance, and Notified Body remediation timelines with structured documentation packages
- Enable consistent PMCF and PMPF documentation across single-device, multi-device, and portfolio-level programs
- Convert survey, literature, registry, retrospective, and real-world evidence outputs into clear regulatory conclusions
- Support continued market access by keeping post-market evidence current, traceable, and review-ready
Frequently Asked Questions (FAQs)
01. What are PMCF and PMPF?
Post-Market Clinical Follow-Up (PMCF) is the EU MDR process for collecting and evaluating clinical data from medical devices after market placement. Post-Market Performance Follow-Up (PMPF) is the EU IVDR process for collecting and evaluating performance and relevant scientific data from IVDs. Both support ongoing evaluation of safety, performance, claims, and benefit-risk acceptability.
02. Does PMCF apply to IVDR?
For IVDs regulated under the EU IVDR, the corresponding post-market follow-up activity is Post-Market Performance Follow-Up (PMPF), not PMCF. PMCF is used for medical devices under the EU MDR, while PMPF is used for IVDs under the EU IVDR.
03. What is the difference between PMCF, PMPF, and PMS?
PMS is the broader post-market surveillance system for collecting and evaluating post-market information throughout the product lifecycle. PMCF is the clinical evidence activity within PMS for medical devices under the EU MDR, while PMPF is the performance evidence activity within PMS for IVDs under the EU IVDR. Both help update evaluation conclusions, risk management, and technical documentation.
04. What should be included in a PMCF Plan?
A PMCF Plan should define the device scope, intended purpose, indications, target population, clinical claims, existing clinical evidence, identified evidence gaps, PMCF objectives, data sources, selected methods, timelines, responsibilities, evaluation criteria, and analysis approach. It should also explain how PMCF results will update the CER, PMS documentation, PMSR/PSUR, risk management, labeling, IFU, and technical documentation.
05. What should be included in a PMPF Plan?
A PMPF Plan should include the IVD scope, intended purpose, performance claims, target population, user environment, existing performance evidence, scientific validity, analytical performance, clinical performance considerations, identified performance evidence gaps, PMPF objectives, performance questions, data sources, selected methods, method rationale, timelines, responsibilities, evaluation criteria, analysis approach, and links to PER, PMS, PMSR/PSUR, RMF, SSP, labeling, IFU, and technical documentation. It should also justify when certain PMPF activities are limited or not applicable.
06. What should be included in a PMCF or PMPF Evaluation Report?
A PMCF or PMPF Evaluation Report should summarize completed follow-up activities, data sources, methods, results, key findings, limitations, residual or emerging risks, benefit-risk impact, and recommendations for future activities. PMCF Evaluation Reports support CER, PMS, PMSR/PSUR, RMF, SSCP, labeling, IFU, and technical documentation updates, while PMPF Evaluation Reports support PER, PMS, PMSR/PSUR, RMF, SSP, labeling, IFU, and technical documentation updates.
07. What methods can be used for PMCF and PMPF?
PMCF and PMPF methods may include literature review, state-of-the-art monitoring, surveys, registry analysis, retrospective data review, real-world evidence analysis, PMCF clinical investigations, PMPF performance studies, complaint and vigilance trend analysis, and structured user or stakeholder feedback.
08. What are the key challenges in developing PMCF and PMPF documentation?
Common challenges include defining appropriate data sources, selecting proportionate methods, linking activities to evidence gaps, ensuring integration with clinical or performance evaluation, interpreting survey or study outputs, maintaining traceability across lifecycle documents, and responding to Notified Body comments or observations.
09. Why is Freyr considered a preferred partner for PMCF and PMPF documentation?
Freyr supports PMCF and PMPF documentation through regulatory, clinical evaluation, performance evaluation, PMS, risk management, and real-world evidence generation expertise. By integrating PMCF and PMPF outputs with CER/PER, PMS, PMSR/PSUR, RMF, SSCP/SSP, labeling, IFU, and technical documentation, Freyr helps manufacturers maintain structured, traceable, and audit-ready post-market evidence documentation.
